Opening statements were given yesterday in the first trial of a South Dakota woman against Johnson & Johnson, the makers of the Ethicon Gynecare Prolift Plus. The trial, which is taking place in Atlantic City, New Jersey because the headquarters of Johnson & Johnson is in New Jersey, is being brought by Linda Goss a 47 year old woman who had 18 revision surgeries to repair the damage done by the transvaginal mesh product placed in her in 2006. Ethicon which marketed the mesh for the repair of pelvic organ prolapse (POP) and stress urinary incontinence (SUI) recently pulled several of the Gynecare products including the Prolift off the market. Other products which were marketed by Ethicon included the Prosima, TVT, TVT-S, and TVT-O.
There are 1800 pending cases against several manufacturers of the mesh products including BARD, American Medical (AMS) and Boston Scientific. The legal team working on behalf of Ms. Goss includes members of the Plaintiff Steering Committee for the national transvaginal mesh litigation team. Sean Keith of our law firm is a member of the committee serving on both the privilege log committee and the document review teams. He along with other members has supported the efforts of the lawyers in New Jersey in pursuing this first and important trial. There are thousand other cases pending in Charleston, West Virginia. Mr. Keith represents clients from throughout the State of Arkansas. He has been a guest speaker on this case and other drug injury cases.